Anke Langbein

ORCID: 0000-0001-9938-1496
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Neurological and metabolic disorders
  • Venous Thromboembolism Diagnosis and Management
  • Financial Markets and Investment Strategies
  • Neurosurgical Procedures and Complications
  • Blood Pressure and Hypertension Studies
  • Neurological Disorders and Treatments
  • Biomedical and Chemical Research
  • ECG Monitoring and Analysis
  • Restraint-Related Deaths
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Airway Management and Intubation Techniques
  • Electrostatic Discharge in Electronics
  • Pneumothorax, Barotrauma, Emphysema
  • Dental Anxiety and Anesthesia Techniques
  • Financial Reporting and Valuation Research
  • Heart Rate Variability and Autonomic Control
  • Medical Practices and Rehabilitation
  • Cardiac tumors and thrombi

Praxis
2025

Orthopädische Praxis
2017-2024

Technische Universität Dresden
2016-2021

Klinik und Poliklinik für Psychotherapie und Psychosomatik
2016-2021

Brandenburg University of Technology Cottbus-Senftenberg
2017

Ruhr University Bochum
2014

Rhön-Klinikum
2009-2014

Westpfalz Klinikum
2013

Electrographic flow (EGF) mapping enables full spatiotemporal reconstruction of organized wavefront propagation to identify extrapulmonary vein sources atrial fibrillation (AF).

10.1016/j.jacep.2024.03.040 article EN cc-by-nc-nd JACC. Clinical electrophysiology 2024-06-05

FIRM Ablation Outcomes for Recurrent Nonparoxysmal AF Introduction A patient‐tailored ablation approach focused on the elimination of both pulmonary vein triggers as well substrate drivers may result in favorable outcomes recurrent persistent patients. Objective We evaluated long‐term rotor combined with conventional isolation (PVI) patients nonparoxysmal AF. Methods Fifty‐eight consecutive underwent FIRM‐guided followed by PVI treatment software algorithm was used to display rotational...

10.1111/jce.13110 article EN Journal of Cardiovascular Electrophysiology 2016-10-21

Abstract Aims Digital health is becoming increasingly powerful and available but frequently not effectively integrated into daily practice. A hybrid programme was developed to provide holistic diagnostic therapeutic patient care in atrial fibrillation. Methods results Patients (n = 68) were recruited at the electrophysiology centre following successful interventional restoration of sinus rhythm. The 12-month consists key modalities: (i) self-recording one-lead electrocardiograms (ECGs), (ii)...

10.1093/ehjdh/ztae099 article EN cc-by-nc European Heart Journal - Digital Health 2025-01-09

Abstract Background Pulmonary vein isolation (PVI) with cryoballoon to treat symptomatic atrial fibrillation (AF) is well established. The most frequent complication during cryoballoon-based PVI phrenic nerve injury. Data on PNI Arctic Front has been described previously. However, data for the balloon system Polar X scarce. purpose of this retrospective study was compare incidence and characteristics between two systems. Methods enrolled patients, who underwent January 2024 October in our...

10.1093/europace/euaf085.216 article EN cc-by-nc EP Europace 2025-05-01

Abstract Background Various randomized multicenter studies have shown that percutaneous left atrial appendage closure (LAAC) is not inferior in stroke prevention compared to vitamin K antagonists (VKA) and can be performed safely effectively. Aims The prospective ORIGINAL registry the Free State of Saxony (saxOnian RegIstry analyzinG followINg Appendage cLosure) investigated efficiency safety LAAC with Watchman or Amulet device a real word setting. A special focus was put on influence...

10.1186/s12872-022-02708-4 article EN cc-by BMC Cardiovascular Disorders 2022-06-16

Pulmonary vein isolation (PVI) for atrial fibrillation (AF) has become increasingly safe and effective with the evolution of single-tip ablation catheters aided by contact force sensing (ST-CF) single-shot devices such as second-generation pulmonary catheter (PVAC) Gold multi-electrode array. The multicentre randomized GOLD FORCE trial was conducted to evaluate non-inferiority safety efficacy PVAC PVI compared ST-CF paroxysmal AF.The primary endpoint documented AF recurrence ≥30 s assessed...

10.1093/europace/euab168 article EN EP Europace 2021-06-15

Abstract Background The current ESC guidelines on atrial fibrillation recommend the assessment of disease burden and rigorous management cardiovascular risk factors. A digital patient care program (Digital Health Program Atrial Fibrillation) was offered to patients following pulmonary vein isolation or cardioversion in cooperation with a major German statutory health insurer leading cardiology clinic. 12 month consists functions: (1) self-recording 1-channel-ECGs by possibility receive...

10.1093/europace/euae102.604 article EN cc-by-nc EP Europace 2024-05-01

Abstract Background Pulsed field ablation (PFA) is a relatively new technology for isolation of pulmonary veins in patients with atrial fibrillation (AF). Data addressing reasons recurrent despite primarily successful vein (PVI) using PFA are scarce, due to an up date limited number treated this way. Objective The aim study was analyze electrophysiological characteristics reconduction and / or left substrate referred our center Re-Do procedures AF after initial PVI PFA. Methods 90 (mean age...

10.1093/europace/euae102.095 article EN cc-by-nc EP Europace 2024-05-01

Im Rahmen einer klinischen Observationsstudie war – vor dem Hintergrund der juristisch erforderlichen Thematisierung mit Patienten Risiken und Alternativen [29, 36], auch angezeigten Lokalanästhesie die Frage zu beantworten, ob intraligamentäre Anästhesie (ILA) als primäre Methode alle Anforderungen an eine weitgehend vollständige patientenschonende zahnärztliche Lokalanästhesiemethode erfüllen kann [8]. Es lag ausschließlich in Entscheidung Patienten, Behandlung unter Leitungs- respektive...

10.1055/s-0032-1327435 article DE ZWR - Das Deutsche Zahnärzteblatt 2012-09-05

Focal impulse and Rotor Modulation (FIRM) has been introduced recently as a new approach for ablation of atrial fibrillation (AF).We report case FIRM-guided rotor ablation, performed in combination with (re)-pulmonary vein isolation patient recurrent persistent AF two previous failed conventional procedures.Four rotors could be detected successfully ablated this patient, one the right atrium three left atrium.Notably, experienced short-term recurrence spontaneous conversion back to sinus...

10.19102/icrm.2016.071101 article EN Journal of Innovations in Cardiac Rhythm Management 2016-12-14

Purpose: Stable electrical rotors and focal sources have been demonstrated to sustain atrial fibrillation (AF). Rotor activity can be using a special computational mapping procedure. The aim of this study is analyze the characteristics course heart rhythm (AF recurrence restoration sinus rhythm) after rotor ablation. Methods: Patients who underwent redo procedure for AF (Focal Impulse Mapping (FIRM) guided ablation additional re-pulmonary vein isolation) were analyzed with respect time (SR)....

10.1093/europace/18.suppl_1.i179b article EN EP Europace 2016-06-01

Purpose: Despite significant progress in catheter techniques suboptimal ablation outcomes are observed for patients with atrial fibrillation (AF). This effect is potentially related to the standard approaches of most which mainly focus on anatomic rather than patient specific functional targets. Recently, two new concepts have been introduced aimed First, stable electrical rotors and focal sources demonstrated sustain AF. Therefore, has associated first studies an improved clinical outcome...

10.1093/europace/18.suppl_1.i179a article EN EP Europace 2016-06-01

Zusammenfassung In der vorliegenden Übersichtsarbeit wird die aktuelle Datenlage zur Thrombembolieprophylaxe und insbesondere Prophylaxe des ischämischen Schlaganfalles bei Patienten mit Vorhofflimmern zusammengefasst bewertet. Die Indikation basiert auf individuellen Risikobewertung z. B. mittels CHA2DS2-VASc- HAS-BLED-Score. Bei oralen Antikoagulation stellen VitaminK-Antagonisten Standardtherapie dar. Sie verhindern etwa zwei Drittel erwarteten Schlaganfälle, führen jedoch jährlich ca. 1%...

10.1055/s-0038-1628153 article DE Nervenheilkunde 2012-01-01
Coming Soon ...